AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Ocrelizumab in Nigeria
1 product registered with NAFDAC — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Ocrevus** Concentrate for solution for infusion | A6-100051 | Roche Products Limited | active | 23 May 2027 |
Ocrelizumab — NAFDAC Registration Details
NAFDAC (Nigeria) has 1 registered product containing Ocrelizumab, of which 1 is currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Ocrelizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.